$0.680
+0.001 (+0.15%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CLDI Prediction & Forecast by Similar Chart Analysis
Alphio's CLDI stock price prediction model matches the current Calidi Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.69 (+0.98%). The 1-week path is $0.72 (+6.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Calidi Biotherapeutics Inc Stock?
Calidi Biotherapeutics is not a good buy right now due to its severe financial losses and delisting risk. The stock has a current price of $0.68, down 96.40% year-to-date, and has a negative forward P/E ratio of 0, indicating no earnings expectations. Additionally, the company faces a compliance notice from the NYSE due to stockholders' equity below the required $4 million, which poses a significant risk of delisting.
CLDI stock price ended at $0.68 on Friday, after rising +0.15%
Calidi Biotherapeutics Inc (CLDI) last closed at $0.68, gaining +0.15%. These facts feed the 1-day and 1-week CLDI price prediction above.
Forecast Drivers
Calidi Biotherapeutics Inc (CLDI) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CLDI, ranked by similarity.
Seasonality analysis for CLDI
Historically the probability of a positive November return for CLDI is 0.00%. February offers the highest probability of a positive month at 20.69%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CLDI
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.45 | $0.53 | $0.62 | -22.09% |
| Dec 2026 | $0.53 | $0.63 | $0.72 | -7.44% |
In 2026, Calidi Biotherapeutics Inc (CLDI) is projected to range from $0.45 to $0.72.
Calidi Biotherapeutics Inc 2026 monthly forecast
In Nov 2026, Calidi Biotherapeutics Inc is projected to average $0.53, with a low of $0.45 and high of $0.62.
In Dec 2026, Calidi Biotherapeutics Inc is projected to average $0.63, with a low of $0.53 and high of $0.72.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.